FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmacology and represents stable pharmaceutical composition for parenteral application, which in one reservoir contains fixed doses of recombinant gamma and alpha 2b interferons for treatment of pathologic phenomena, characterised by benign non-physiological or malignant cell growth of tissues or organs, and which additionally contains pharmaceutically acceptable filling agents or carriers.
EFFECT: invention ensures higher tumour treatment efficiency due to synergic impact of composition components, as well as composition stability.
18 cl, 14 ex, 19 tbl, 9 dwg
| Title |
Year |
Author |
Number |
| METHOD FOR MAKING RECOMBINANT HUMAN ALPHA 16-INTERFERON AND PHARMACEUTICAL COMPOSITION FOR TREATING VIRAL DISEASES BASED ON RECOMBINANT HUMAN ALPHA 16-INTERFERON |
2007 |
- Padkina Marina Vladimirovna
- Dobrogorskaja Marina Vladimirovna
- Karabel'Skij Aleksandr Vladimirovich
- Sambuk Elena Viktorovna
- Smirnov Mikhail Nikolaevich
|
RU2380405C2 |
| POLYETHYLENE GLYCOL MODIFIED INTERFERON ALPHA 2B, PRODUCING AND USING PREPARATION |
2007 |
- Tskhou Vajdong
- Ksiao Kvingdzhiang
- Sun Li
- Vang Tibing
- Jin Fengkhong
- Luo Shikhong
- Shuang Lu
- Liu Min
- Ksu Tianle
- Shang Jong
|
RU2485134C2 |
| FUSED PROTEIN ELICITING BIOLOGICAL ACTIVITY OF INTERFERON-ALPHA, DIMERIC FUSED PROTEIN, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF, DNA MOLECULE (VARIANTS) AND METHOD FOR TARGETING INTERFERON-ALPHA INTO LIVER TISSUE |
2000 |
- Sun Japing
- Dzhilliz Stefen D.
- Lo Kin-Ming
|
RU2262510C9 |
| FUSION PROTEIN, ESCHERICHIA COLI STRAIN BEING FUSION PROTEIN PRODUCER AND METHOD FOR PRODUCING METHIONINE-FREE HUMAN INTERFERON ALPHA-2b OF SUCH FUSION PROTEIN |
2010 |
- Kozlov Dmitrij Georgievich
- Cheperegin Sergej Ehduardovich
- Gubajdullin Irek Il'Jasovich
- Jakovenko Andrej Romanovich
- Kazarov Aleksandr Aleksandrovich
|
RU2441072C1 |
| PROTEIN SHOWING INTERFERON-LIKE ANTIVIRAL AND ANTIPROLIFERATIVE BIOLOGICAL ACTIVITIES (VERSIONS), PROTEIN STRUCTURE, CODING POLYNUCLEOTIDE (VERSIONS), EXPRESSION VECTOR, HOST CELL, COMPOSITION AND USE OF PROTEIN AS ANTIVIRAL, ANTIPROLIFERATIVE, ANTICANCER OR IMMUNOMODULATORY AGENT AND METHOD OF TREATING CONDITION SENSITIVE TO INTERFERON-THERAPY, CANCER OR VIRAL DISEASE |
2007 |
- Van Khajtao
- Mao Chunshen
- Li Tszichzhi
- Van Lin
- Du Jun
- Lju Lunbin'
- Sjuj Tszin
- Chzhan Zhuj
|
RU2469091C2 |
| STABILIZED COMPOSITION POSSESSING ANTIVIRAL, ANTICANCER, IMMUNOMODULATORY, ACTOPROTECTIVE, ANTIMUTAGENIC AND ANTIOXIDANT ACTIVITY |
2018 |
- Chumburidze Georgij Georgievich
|
RU2690677C1 |
| HYBRID PROTEIN (VERSIONS), BACTERIAL STRAIN ESCHERICHIA COLI - HYBRID PROTEIN PRODUCER (VERSIONS) AND METHOD FOR PRODUCING METHIONINE-FREE HUMAN INTERFERON ALPHA-2 |
2011 |
- Kozlov Dmitrij Georgievich
- Jakovenko Andrej Romanovich
- Tezov Vladimir Adol'Fovich
|
RU2453604C1 |
| METHODS AND PREPARATIONS FOR TREATMENT OF PATIENTS WITH INTERFERON EXHIBITING DECREASED ADVERSE EFFECTS |
1993 |
- Blatt Lourens M.
- Tejlor Milton U.
|
RU2128056C1 |
| RECOMBINANT PLASMID PFM-IFN-17 PROVIDING EXPRESSION OF INTERFERON ALPHA-2B OF HUMAN, RECOMBINANT PLASMID PFM-AP, PROVIDING EXPRESSION OF ENZYME METHIONINE-AMINOPEPTIDASE E COLI, BIPLASMID STRAIN ESCHERICHIA COLI FM-IFN-AP (PFM-IFN-17, PFM-AP) - PRODUCER (MET-) OF RECOMBINANT INTERFERON ALPHA -2B OF HUMAN |
2016 |
- Markov Ilya Aleksandrovich
- Markova Elena Alekseevna
- Gaponyuk Polina Petrovna
- Markova Inna Nikolaevna
|
RU2610173C1 |
| ALPHA-INTERFERON PREPARATION IN THE FORM OF STABLE AQUEOUS SOLUTION FOR INJECTIONS |
2004 |
|
RU2255729C1 |
